Filana Therapeutics (FLNA) Assets (2010 - 2026)
Filana Therapeutics (FLNA) posted quarterly Assets of $103.9 million for Q2 2026, down 23.25% year-over-year from $135.4 million in Q2 2025, and down 4.12% quarter-over-quarter from $108.4 million in Q1 2026.
Filana Therapeutics (FLNA) Assets (2010 - 2026) Analysis & Trends
Filana Therapeutics' Assets history runs 17 years deep, the most recent figure standing at $103.9 million for Q2 2026.
- In Q2 2026, Assets fell 23.25% year-over-year to $103.9 million; the TTM figure through Jun 2026 stood at $103.9 million (down 23.25% YoY), while the FY2025 annual figure was $118.4 million, down 24.87% from the prior year.
- Assets for Q2 2026 stood at $103.9 million, down from $108.4 million in the prior quarter.
- The five-year high for Assets was $244.2 million in Q1 2022, with the low at $103.9 million in Q2 2026.
- The 5-year median for Assets is $165.0 million (2023), against an average of $176.1 million.
- The sharpest annual moves came in 2024 and 2025: Assets grew 29.69% in 2024, then plunged 44.42% in 2025.
- Filana Therapeutics' Assets stood at $234.8 million in 2022, then slumped by 35.42% to $151.7 million in 2023, then gained by 3.87% to $157.5 million in 2024, then dropped by 24.87% to $118.4 million in 2025, then declined by 12.21% to $103.9 million in 2026.
- Business Quant data shows FLNA's Assets at $103.9 million in Q2 2026, $108.4 million in Q1 2026, and $118.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | 103.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 103.90 Mn |
| Mar 31, 2026 | 108.37 Mn |
| Dec 31, 2025 | 118.36 Mn |
| Sep 30, 2025 | 129.73 Mn |
| Jun 30, 2025 | 135.38 Mn |
| Mar 31, 2025 | 140.93 Mn |
| Dec 31, 2024 | 157.53 Mn |
| Sep 30, 2024 | 223.75 Mn |
| Jun 30, 2024 | 243.57 Mn |
| Mar 31, 2024 | 155.72 Mn |
| Dec 31, 2023 | 151.66 Mn |
| Sep 30, 2023 | 172.53 Mn |
| Jun 30, 2023 | 197.25 Mn |
| Mar 31, 2023 | 218.11 Mn |
| Dec 31, 2022 | 234.83 Mn |
| Sep 30, 2022 | 207.29 Mn |
| Jun 30, 2022 | 227.38 Mn |
| Mar 31, 2022 | 244.19 Mn |
| Dec 31, 2021 | 266.78 Mn |
| Sep 30, 2021 | 274.25 Mn |